Midterm Exam

Question 1

How do the healthcare and insurance industries inhibit recognition of EAIs?

Answer 1

1. Lack of consideration for chemical and microbial exposures over various life stages
2. Lack of reimbursements for holistic health treatments
3. Lack of diagnostic codes

Question 2

How might physicians take advantage of EAI patients?

Answer 2

1. Purposeful misdiagnosis
2. Application of unproven treatments
3. Lengthening of uncertain treatments for rare diseases

Question 3

Diagnosis and treatment of EAI requires:

Answer 3

1. Consideration of multiple hazard exposures and combined effects
2. A One Health approach
3. Consideration of individual susceptibility factors
4. Consideration of long-term, chronic health outcomes

Question 4

The traditional medical model was designed to identify a singular cause of a particular illness

Answer 4

True

Question 5

Symptoms that point toward mold toxicity in a person include:

Answer 5

1. Electric shock sensations
2. Vibrating or pulsing sensations running up and down the spinal cord
3. Ice pick-like pains

Question 6

Place the following in the correct order to diagnosis and treat mold toxicity

Answer 6

1. Evaluate your environment
2. Conduct mycotoxin testing
3. Add binders
4. Add oral and/or nasal antifungals

Question 7

What are considered triggers of mast cell activation?

Answer 7

1. Lyme disease
2. Mold exposures
3. Infectious agents

Question 8

According to Naviaux’s fundamental premise, chronic disease management models should focus on the current state of the patient

Answer 8

False

Question 9

Brain MRIs with NeuroQuant imaging is useful for diagnosis of EAIs

Answer 9

True

Question 10

Tight junction protein(s)

Answer 10

Play an important role in blocking transport of toxins into cells

Question 11

Cognitive issues are not attributed to mycotoxicity

Answer 11

False

Question 12

Mast cell activation in the intestinal wall leads to tight cellular junctions

Answer 12

False

Question 13

LDN

Answer 13

An atypical anti-inflammatory medication used to treat fibromyalgia

Question 14

Cytokines

Answer 14

inflammatory biomarkers

Question 15

granules

Answer 15

produced by mast cells; rich in histamine

Question 16

CDR

Answer 16

A sequence of events lead by the mitochondrial response

Question 17

Lymphatic system

Answer 17

Involved in draining waste products from the body

Question 18

Phosphatidylcholine

Answer 18

Treatement used to remove mold toxins

Question 19

M1

Answer 19

Pro-inflammatory mitochondria

Question 20

M2

Answer 20

Anti-inflammatory mitochondria

Question 21

Patients with environmental sensitivities are:

Answer 21

1. Complex to treat

2. Increasing in number/frequency